Attention Deficit/Hyperactivity Disorder (AD/HD) is a complex heterogeneous, chronic and pervasive developmental disorder that is influenced by both genetic and environmental factors. The worldwide prevalence of ADHD is approximately 5% of children and 2.5% of adults in most cultures, with higher prevalence figures in some jurisdictions, such as the United States of America, where the prevalence rate is considerably higher (10.2% for children) (APA, 2013; NHS, 2008; WHO, 1993).
In clinical settings, accurately diagnosing and treating AD/HD can take a considerable amount of valuable clinical time. The typical clinical assessment process can be lengthy and can involve the administration and scoring of numerous subjective rating scales, observation in multiple settings and lengthy differential assessments involving multiple disciplines (APA, 2013; NHS, 2008).
At AIT we have created the Multimodal Interactive Neuropsychological Diagnostic (MIND) assessment for AD/HD.
For more Information, please contact:
Dr. Sean Brennan, Clinical Psychologist and AIT Researcher: firstname.lastname@example.org
Dr. Niall Murray, AIT Lecturer and Researcher: email@example.com